Ceram, the materials technology company, has published a white paper, ‘Multi-Substituted Hydroxyapatites and the Role They Can Play in Enhanced Bone Replacement Solutions’.
The white paper, whilst giving a brief introduction of the opportunities for synthetic HA (and associated structures) in bone replacement, focuses on substituted Hydroxyapatite.
Some results from a recently completed study on multi-substituted HA - carried out to find out how mean ionic volume and charge impact on the yield of the crystalline HA - are discussed.
All HA work reported is based on computer controlled wet precipitation production routes under mild conditions that should be scalable.
With their newly-patented technology, Ceram’s aim is to work with clients to develop HA with tailored bioactivity, both for bone replacement materials applications and for new drug delivery systems with tailored bio-application requirements.
To download the white paper, please click on the link above.
